Total Payments
$6,231
2024 Payments
$2,332
Companies
37
Transactions
271
Medicare Patients
924
Medicare Billing
$77,754
Payment Breakdown by Category
Food & Beverage$6,084 (97.6%)
Education$147.68 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,084 | 268 | 97.6% |
| Education | $147.68 | 3 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $859.28 | 44 | $0 (2024) |
| ABBVIE INC. | $786.99 | 58 | $0 (2024) |
| Amgen Inc. | $612.97 | 19 | $0 (2024) |
| PFIZER INC. | $434.04 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $377.88 | 8 | $0 (2024) |
| Lilly USA, LLC | $304.21 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $298.23 | 20 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $228.65 | 5 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $223.13 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $202.21 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,332 | 98 | Novo Nordisk Inc ($304.76) |
| 2023 | $2,292 | 99 | Amgen Inc. ($419.57) |
| 2022 | $812.99 | 38 | Novo Nordisk Inc ($265.46) |
| 2021 | $794.67 | 36 | AbbVie Inc. ($258.66) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Biological | ||||||
| 12/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: VACCINES | ||||||
| 12/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $17.69 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.21 | General |
| 11/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: HIV | ||||||
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.40 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 350 | 454 | $127,355 | $32,737 |
| 2022 | 7 | 167 | 242 | $67,103 | $13,917 |
| 2021 | 6 | 215 | 301 | $72,968 | $17,651 |
| 2020 | 4 | 192 | 246 | $43,389 | $13,450 |
Total Patients
924
Total Services
1,243
Medicare Billing
$77,754
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 139 | $46,498 | $8,993 | 19.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 56 | 56 | $19,100 | $5,895 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 56 | $26,159 | $5,488 | 21.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $7,066 | $5,087 | 72.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 80 | $18,836 | $4,527 | 24.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,188 | $828.35 | 69.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,616 | $646.80 | 11.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $918.00 | $552.42 | 60.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $844.00 | $401.76 | 47.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 22 | $879.34 | $264.22 | 30.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 15 | 21 | $250.11 | $52.50 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 122 | $40,811 | $8,045 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 25 | $11,678 | $2,662 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $4,093 | $1,286 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $4,709 | $1,036 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,184 | $760.87 | 14.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 24 | 37 | $440.67 | $84.60 | 19.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $187.04 | $41.97 | 22.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 127 | $42,115 | $9,340 | 22.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 77 | $17,384 | $5,010 | 28.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $8,207 | $1,687 | 20.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $4,434 | $1,417 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 31 | 37 | $494.32 | $111.00 | 22.5% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 20 | 28 | $333.11 | $85.92 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 143 | 179 | $30,813 | $9,918 | 32.2% |
About Alyssa Rollins, PA
Alyssa Rollins, PA is a Physician Assistant healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1225569395.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alyssa Rollins, PA has received a total of $6,231 in payments from pharmaceutical and medical device companies, with $2,332 received in 2024. These payments were reported across 271 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,084).
As a Medicare-enrolled provider, Rollins has provided services to 924 Medicare beneficiaries, totaling 1,243 services with total Medicare billing of $77,754. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Salem, OR
- Active Since 03/21/2017
- Last Updated 03/30/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1225569395
Products in Payments
- NURTEC ODT (Drug) $543.35
- JARDIANCE (Drug) $327.07
- Ozempic (Drug) $320.64
- EVENITY (Biological) $307.23
- Kerendia (Drug) $298.23
- Wegovy (Drug) $257.67
- VRAYLAR (Drug) $257.47
- QULIPTA (Drug) $254.56
- UBRELVY (Drug) $206.04
- SPRAVATO (Drug) $202.21
- ELIQUIS (Drug) $196.44
- APRETUDE (Biological) $176.02
- REXULTI (Drug) $148.14
- Rybelsus (Drug) $142.97
- CAPLYTA (Drug) $130.00
- Otezla (Drug) $129.58
- ZENPEP (Drug) $125.01
- AREXVY (Drug) $125.00
- Repatha (Biological) $125.00
- BEXSERO (Biological) $118.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Salem
Shawn Hill, Mpas, MPAS
Physician Assistant — Payments: $16,101
Physician Assistant $16,101
Mrs. Olivia Darwin, Pa-C, PA-C
Physician Assistant — Payments: $9,122
Physician Assistant $9,122
Shannon Snyder, Pa-C, PA-C
Physician Assistant — Payments: $8,469
Physician Assistant $8,469
Eric Harmon, Pa, PA
Physician Assistant — Payments: $8,455
Physician Assistant $8,455
Robert Wollenzien
Physician Assistant — Payments: $7,551
Physician Assistant $7,551
Jordan Young, Pa-C, PA-C
Physician Assistant — Payments: $7,356
Physician Assistant $7,356